Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.

Oral squamous cell carcinoma

Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC). A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma Patients Efficacy and Safety of Neoadjuvant Pembrolizumab in III -IVA Resectable Oral Squamous Cell Carcinoma Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and Surgery Pembrolizumab Alone or in Combination With Ipatasertib for the Treatment of Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002) A Study to Evaluate the Efficacy of Neoadjuvant DaRT for Advanced Oral Cavity SCC Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma Pembrolizumab and Radiation Therapy Before and During Surgery for the Treatment of Persistent or Recurrent Head and Neck Cancer Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Added to Radiation or Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery Ganetespib Window of Opportunity Study in Head and Neck Cancers Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM) Biofeedback Rehabilitation to Improve Speaking and Eating in Public Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Oral Cavity Squamous Cell Carcinoma Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer Human Papillomavirus on Oral Tissue, Saliva and Serum Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma